Literature DB >> 18254688

Psychodynamic and cognitive-behavioral approaches of obsessive-compulsive disorder: is it time to work through our ambivalence?

Stefan Kempke1, Patrick Luyten.   

Abstract

This paper provides an overview of the growing convergence among psychodynamic and cognitive-behavioral approaches of Obsessive-Compulsive Disorder (OCD). From a traditional psychoanalytic point of view, OCD is mainly conceptualized in terms of a constant conflict between feelings of love and hate. More recent psychodynamic theories of OCD, such as the object-relational model, focus on the role of ambivalent mental representations or cognitive-affective schemas of self and others. This notion of mental representations or schemas links psychodynamic formulations to cognitive-behavioral approaches of OCD. Moreover, there is increasing overlap between psychodynamic and cognitive-behavioral models concerning the core dynamics involved in OCD. Implications of this convergence for future research and clinical practice are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 18254688     DOI: 10.1521/bumc.2007.71.4.291

Source DB:  PubMed          Journal:  Bull Menninger Clin        ISSN: 0025-9284


  3 in total

1.  Cognitive schemas among mental health professionals: Adaptive or maladaptive?

Authors:  Sahoo Saddichha; Ajay Kumar; Nirmala Pradhan
Journal:  J Res Med Sci       Date:  2012-06       Impact factor: 1.852

2.  How to treat the untreated: effectiveness of a self-help metacognitive training program (myMCT) for obsessive-compulsive disorder.

Authors:  Steffen Moritz; Lena Jelinek; Marit Hauschildt; Dieter Naber
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

3.  Anger and aggressiveness in obsessive-compulsive disorder (OCD) and the mediating role of responsibility, non-acceptance of emotions, and social desirability.

Authors:  Barbara Cludius; Anna K Mannsfeld; Alexander F Schmidt; Lena Jelinek
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-11-05       Impact factor: 5.270

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.